Encompass Health (NYSE:EHC) Updates FY24 Earnings Guidance

Encompass Health (NYSE:EHC) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.86-4.11 for the period, compared to the consensus estimate of $3.98. The company issued revenue guidance of $5.250-5.325 billion, compared to the consensus revenue estimate of $5.25 billion.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on EHC shares. Barclays increased their price target on shares of Encompass Health from $95.00 to $101.00 and gave the stock an overweight rating in a report on Thursday, March 28th. Truist Financial raised their price objective on shares of Encompass Health from $82.00 to $86.00 and gave the stock a buy rating in a report on Friday, February 9th. William Blair reissued an outperform rating on shares of Encompass Health in a research note on Wednesday, February 7th. Stephens reiterated an overweight rating and issued a $85.00 target price on shares of Encompass Health in a report on Tuesday, January 16th. Finally, Mizuho increased their price objective on shares of Encompass Health from $77.00 to $82.00 and gave the stock a buy rating in a report on Friday, February 9th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Encompass Health presently has an average rating of Buy and a consensus target price of $83.22.

Encompass Health Stock Performance

Shares of NYSE:EHC traded up $0.34 on Wednesday, hitting $82.80. The company had a trading volume of 1,173,108 shares, compared to its average volume of 659,644. The stock has a 50 day moving average price of $77.70 and a 200 day moving average price of $70.59. The stock has a market cap of $8.29 billion, a price-to-earnings ratio of 23.76, a P/E/G ratio of 1.49 and a beta of 0.94. Encompass Health has a 1-year low of $57.55 and a 1-year high of $83.73. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The firm had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. Analysts expect that Encompass Health will post 3.96 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.72%. The ex-dividend date was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is presently 17.29%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.